Literature DB >> 19656962

Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice.

Diane L Ritchie1, Aileen Boyle2, Irene McConnell2, Mark W Head1, James W Ironside1, Moira E Bruce2.   

Abstract

Prion strains are defined by their biological properties after transmission to wild-type mice, specifically by their incubation periods and patterns of vacuolar pathology ('lesion profiles'). Preliminary results from transmissions of variant Creutzfeldt-Jakob disease (vCJD) to wild-type mice provided the first compelling evidence for the close similarity of the vCJD agent to the agent causing bovine spongiform encephalopathy (BSE). Complete results from this investigation, including the transmission characteristics of vCJD from brain and peripheral tissues of 10 cases (after primary transmission and subsequent mouse-to-mouse passage), have now been analysed. All 10 vCJD sources resulted in consistent incubation periods and lesion profiles, suggesting that all 10 patients were infected with the same strain of agent. Incubation periods suggested that infectious titres may be subject to regional variation within the brain. Comparison of incubation periods and lesion profiles from transmission of brain and peripheral tissues showed no evidence of tissue-specific modification in the biological properties of the agent. Analysis of the protease-resistant prion protein (PrP(res)) by Western blotting from primary and subsequent passages in mice showed a glycosylation pattern closely resembling that of vCJD in humans, the so-called BSE 'glycoform signature'. Minor variations in PrP(res) fragment size were evident between mouse strains carrying different alleles of the gene encoding PrP both in primary transmissions and on further passages of vCJD brain. Overall, the results closely resembled those of previously reported transmissions of BSE in the same mouse strains, consistent with BSE being the origin of all of these vCJD cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656962     DOI: 10.1099/vir.0.013227-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

3.  Classical bovine spongiform encephalopathy by transmission of H-type prion in homologous prion protein context.

Authors:  Juan-María Torres; Olivier Andréoletti; Caroline Lacroux; Irene Prieto; Patricia Lorenzo; Magdalena Larska; Thierry Baron; Juan-Carlos Espinosa
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

4.  Use of murine bioassay to resolve ovine transmissible spongiform encephalopathy cases showing a bovine spongiform encephalopathy molecular profile.

Authors:  Katy E Beck; Rosemary E Sallis; Richard Lockey; Christopher M Vickery; Vincent Béringue; Hubert Laude; Thomas M Holder; Leigh Thorne; Linda A Terry; Anna C Tout; Dhanushka Jayasena; Peter C Griffiths; Saira Cawthraw; Richard Ellis; Anne Balkema-Buschmann; Martin H Groschup; Marion M Simmons; John Spiropoulos
Journal:  Brain Pathol       Date:  2011-10-13       Impact factor: 6.508

Review 5.  Variant CJD. 18 years of research and surveillance.

Authors:  Abigail B Diack; Mark W Head; Sandra McCutcheon; Aileen Boyle; Richard Knight; James W Ironside; Jean C Manson; Robert G Will
Journal:  Prion       Date:  2014-11-01       Impact factor: 3.931

6.  Similarities of Variant Creutzfeldt-Jakob Disease Strain in Mother and Son in Spain to UK Reference Case.

Authors:  Abigail B Diack; Aileen Boyle; Diane Ritchie; Chris Plinston; Dorothy Kisielewski; Jesús de Pedro-Cuesta; Alberto Rábano; Robert G Will; Jean C Manson
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

7.  Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.

Authors:  Matthew T Bishop; Abigail B Diack; Diane L Ritchie; James W Ironside; Robert G Will; Jean C Manson
Journal:  Brain       Date:  2013-02-28       Impact factor: 13.501

8.  Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries.

Authors:  Abigail B Diack; Diane Ritchie; Matthew Bishop; Victoria Pinion; Jean-Philippe Brandel; Stephane Haik; Fabrizio Tagliavini; Cornelia Van Duijn; Ermias D Belay; Pierluigi Gambetti; Lawrence B Schonberger; Pedro Piccardo; Robert G Will; Jean C Manson
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

9.  Changes in retinal function and morphology are early clinical signs of disease in cattle with bovine spongiform encephalopathy.

Authors:  M Heather West Greenlee; Jodi D Smith; Ekundayo M Platt; Jessica R Juarez; Leo L Timms; Justin J Greenlee
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

Review 10.  Public health risks from subclinical variant CJD.

Authors:  Abigail B Diack; Robert G Will; Jean C Manson
Journal:  PLoS Pathog       Date:  2017-11-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.